Radiopharm Theranostics Limited (RADX)

NASDAQ: RADX · Real-Time Price · USD

4.150

+0.150 (3.75%)

May 2, 2025, 4:00 PM EDT - Market closed

Radiopharm Theranostics Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '25 May 2, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Capitalization	34	12	24	26	-
Market Cap Growth	73.79%	-50.78%	-10.18%	-	-
Enterprise Value	10	10	8	4	-
PS Ratio	167.58	8.93	5.74	-	-
PB Ratio	1.07	0.64	0.78	0.61	-
P/TBV Ratio	10.65	-	-	5.56	-
EV/Sales Ratio	50.09	8.02	2.04	-	-
Debt / Equity Ratio	-	-	-	-	-0.47
Asset Turnover	0.00	0.03	0.08	-	-
Quick Ratio	3.25	1.11	1.22	3.43	0.21
Current Ratio	3.37	1.30	1.23	3.46	0.21
Return on Equity (ROE)	-112.21%	-131.49%	-63.78%	-96.82%	-
Return on Assets (ROA)	-28.95%	-30.04%	-22.57%	-29.86%	-
Return on Capital (ROIC)	-59.05%	-60.55%	-32.93%	-39.60%	-
Earnings Yield	-77.61%	-274.09%	-97.15%	-79.40%	-
FCF Yield	-63.02%	-131.34%	-65.25%	-25.86%	-
Buyback Yield / Dilution	-243.78%	-26.36%	-68.74%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q